EME OD Tablet MD
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Palonosetron (0.5mg)
Overview EME OD Tablet MD
MD EME OD tablets offer antiemetic relief, effectively managing nausea and vomiting stemming from various sources, including digestive upset. This medication also proves beneficial in preventing post-surgical nausea and vomiting, as well as that induced by cancer therapies (chemotherapy and radiotherapy). However, it won't alleviate all cancer treatment side effects and is less effective against motion sickness-related vomiting. Always adhere to your physician's prescribed dosage and schedule; consistent timing is recommended. Never discontinue treatment abruptly without consulting your doctor. If vomiting occurs within an hour of ingestion, repeat the dose and avoid large meals that day. Headache and constipation are frequently reported side effects, alongside potential dizziness and drowsiness. Refrain from driving or mentally demanding tasks until the drug's effects are known. These side effects usually subside upon cessation of the medication, but persistent or bothersome symptoms warrant medical consultation for potential management strategies. Prior to initiating treatment, inform your doctor of any pre-existing heart or liver conditions, gastrointestinal obstructions, and all other medications you are taking, especially those for epilepsy, heart disease, cancer, or depression, as interactions may occur. Pregnant or breastfeeding individuals should seek guidance from their healthcare provider.
Uses of EME OD Tablet MD
Sickness | Emesis
Major Benefits of EME OD Tablet MD:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Avoid contact with the tablets using damp hands. Place the tablet in your mouth; however, refrain from swallowing immediately. The EME OD Tablet MD can be consumed with or without food, though consistent daily timing is recommended.
Common Side effects of EME OD Tablet MD:
- Constipation
- Headache
- Diarrhea
- Dizziness
How to use EME OD Tablet MD:
Administer this medication according to your physician's prescribed dosage and schedule. Avoid handling the tablets with damp hands. Place the tablet in your mouth, but refrain from swallowing immediately. EME OD Tablet MD can be ingested with or without food, although consistent timing is recommended.
How EME OD Tablet MD works:
MD Tablet EME OD is an anti-vomiting drug. Its mechanism involves inhibiting serotonin, a neurotransmitter in the brain, thereby preventing chemotherapy-induced or post-surgical nausea and vomiting.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside EME OD Tablet MD is not advised due to unknown safety implications. Seek medical guidance before combining them.
PregnancySAFE IF PRESCRIBED
The use of EME OD Tablet MD during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
The use of EME OD Tablet MD while breastfeeding is likely safe. Available data from human studies indicate minimal risk to the infant.
DrivingUNSAFE
Taking EME OD Tablet MD might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
EME OD Tablet MD poses no safety concerns for patients with kidney impairment; no alteration of the prescribed dosage is necessary.
LiverSAFE IF PRESCRIBED
EME OD Tablet MD poses no safety concerns for patients with hepatic impairment; no dosage modification is necessary.
What if you forget to take EME OD Tablet MD :
Should you forget to take your EME OD Tablet MD, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About EME OD Tablet MD
| Label | Value |
|---|---|
| Chemical Category | Isoquinoline and Quinuclidine-based Derivatives |
| Developing Habits | No. |
| Type of Therapy | Gastrointestinal system |
| Actions | 5-HT3 receptor blockers |






